|
Characteristic
| |
Post-XP empirical Rx
|
No post-XP empirical Rx
|
Total
|
P-value
|
|---|
|
Total (n [%])
| |
22
|
130
|
152
| |
|
Age (mean [SD])
| |
36 (12)
|
41 (11)
|
40 (10)
|
0.04
|
|
Female sex (n [%])
| |
13 (59.1)
|
71 (54.6)
|
84 (55.3)
|
0.70
|
|
CD4 count (median [IQR])*
| |
239 (139, 329)
|
289 (133, 456)
|
283 (133, 441)
|
0.25
|
|
ART at presentation
| |
12 (54.5)
|
69 (53.1)
|
81 (53.3)
|
0.90
|
|
Prior TB treatment (n [%])
| |
1 (4.5)
|
25 (19.2)
|
26 (17.1)
|
0.09
|
|
Symptomatology at presentation (n [%])
|
Cough
|
21 (95.5)
|
129 (99.2)
|
150 (98.7)
|
0.15
|
|
Fever
|
16 (72.7)
|
91 (70)
|
107 (70.4)
|
0.80
|
|
Night sweats
|
11 (50)
|
61 (46.9)
|
72 (47.4)
|
0.79
|
|
Weight loss
|
10 (45.5)
|
38 (29.2)
|
48 (31.6)
|
0.13
|
|
Anorexia
|
13 (59.1)
|
55 (42.3)
|
68 (44.7)
|
0.14
|
|
Chest pain
|
8 (36.4)
|
42 (32.3)
|
50 (32.9)
|
0.70
|
-
IQR interquartile range, n number, Rx treatment, SD standard deviation, TB tuberculosis, XP Xpert® MTB/RIF
- *On 17, 118 and 135 patients, respectively
